“Neoadjuvant Lenvatinib in Advanced Unresectable Thyroid Carcinoma: Case Series and Literature Review”, eCl, vol. 13, no. 1, pp. 6–11, Jan. 2025, doi: 10.35790/ecl.v13i1.58793.